Author

Michael L. Mallory

University of North Carolina at Chapel HillORCID 0000-0003-0768-572XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

John M. PowersiD· 3 shared Ralph Steven BariciD· 3 shared Douglas R. Townsend· 2 shared George GeorgiouiD· 2 shared Gregory C. IppolitoiD· 2 shared Jason J. LavinderiD· 2 shared Jason S. McLellaniD· 2 shared Miranda L. HubbardiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

John M. PowersORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 8, 2026

Broad Sarbecovirus Neutralization by an S2-Directed Plasma Antibody Defines a New Site of Vulnerability in SARS-like Viruses

Douglas R. Townsend, Ling Zhou, Michael L. Mallory…·Jason J. Lavinder

The paper identifies a broadly neutralizing antibody targeting the S2 subunit of sarbecoviruses, revealing a conserved site of vulnerability in the spike protein.

DOI 10.64898/2026.06.06.730562

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJul 16, 2025

Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c Mice

John M. Powers, Sarah R. Leist, Naveenchandra Suryadevara…·Ralph Steven Baric

This paper develops a mouse model of SARS-CoV-2 BA.5 infection that induces fibrotic lung disease and tertiary lymphoid structures, enabling study of acute and post-acute sequelae of COVID-19.

DOI 10.1101/2025.07.16.665104

mouseexperimental assay

𝕏 PostBluesky

ImmunologyCell Reports MedicinePeer-reviewedAug 1, 2024

Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination

William N. Voss, Michael L. Mallory, Patrick O. Byrne…·Gregory C. Ippolito

This study compares IgG antibody responses from SARS-CoV-2 infection, vaccination, and hybrid immunity, finding that hybrid immunity retains the imprint of the initial exposure and enhances antibody breadth and affinity.

48 citationstop 1%

humanproteomics

𝕏 PostBluesky